Literature DB >> 6215490

Defective suppressor cell activity in essential mixed cryoglobulinemia.

P L Meroni, W Barcellini, C Messina, G De Bartolo, F Capsoni, F Invernizzi.   

Abstract

Peripheral blood mononuclear cells from patients with essential mixed cryoglobulinemia were investigated for the ability to induce suppressor cell activity (S.C.A.) following in vitro exposure to Concanavalin A (Con A). The generation of Con A-S.C.A. is significantly impaired in essential mixed cryoglobulinemia compared to the healthy controls. No correlation was found between Con A-S.C.A. and the clinical or laboratory parameters of the disease. This impaired ability to induce Con A-S.C.A. in essential mixed cryoglobulinemia reflects a functional T-cell defect, which may play a role in the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6215490

Source DB:  PubMed          Journal:  J Clin Lab Immunol        ISSN: 0141-2760


  4 in total

1.  Increased frequency of antibodies to ubiquitous viruses in essential mixed cryoglobulinaemia.

Authors:  G Fiorini; P Bernasconi; R A Sinico; R Chianese; F Pozzi; G D'Amico
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

2.  Effect of subcutaneous thymopentin treatment in drug addicts with persistent generalized lymphadenopathy.

Authors:  W Barcellini; P L Meroni; D Frasca; C Sguotti; M O Borghi; C Uberti-Foppa; P Buzzetti; A Lazzarin; G Doria; M Moroni
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

3.  Spontaneous and pokeweed mitogen induced production of rheumatoid factor and immunoglobulins in type II essential mixed cryoglobulinaemia.

Authors:  R A Sinico; G Fiorini; A Fornasieri; P Bernasconi; S Benuzzi; M L Paracchini; G D'Amico
Journal:  Ann Rheum Dis       Date:  1986-07       Impact factor: 19.103

4.  In vitro synthesis of IgM rheumatoid factor by lymphocytes from patients with essential mixed cryoglobulinemia.

Authors:  P L Meroni; W Barcellini; R A Sinico; A Fornasieri; C Sguotti; F Invernizzi; G D'Amico; C Zanussi
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.